Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug composition for treating rhinitis

A composition and drug technology, applied in the directions of drug combinations, active ingredients of hydroxy compounds, pharmaceutical formulations, etc., can solve the problems of difficult treatment and recovery, less obvious effects, etc.

Inactive Publication Date: 2014-02-19
钱家美
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the methods for treating rhinitis are treated by antibiotics, antihistamines and traditional Chinese medicines such as Biyankang and Huodan Pills. Serious cases need to be treated with laser and surgery, but the effect is not obvious, and it is not easy to treat and recover. come a lot of pain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] A pharmaceutical composition for treating rhinitis comprises the following raw materials in parts by weight: 30 grams of dandelion, 20 grams of Cortex Phellodendri, 30 grams of Chuanxiong, 30 grams of orange peel, 20 grams of pinellia, 30 grams of aster, 20 grams of trichosanthin, 3 grams of menthol, 2 grams of artificial musk, 3 grams of borneol, 3 grams of diphenhydramine, 3 grams of camphor, 4 grams of methyl salicylate, 5 grams of belladonna liquid extract.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a drug composition for treating rhinitis. The drug composition comprises the following raw materials by weight: 20-40 g of dandelion, 15-30 g of golden cypress, 20-40 g of ligusticum wallichii, 20-40 g of dried orange peels, 15-30 g of pinellia ternate, 20-40 g of aster, 15-30 g of radices trichosanthis, 1-5 g of menthol, 0.5-4 g of muscone, 1-5 g of borneol, 1-5 g of diphenhydramine, 1-5 g of camphor, 3-6 g of methyl salicylate and 3-7 g of a belladonna liquid extract. The raw materials also can be prepared into ointments according to a conventional preparation method. The drug composition is used for treating the rhinitis, has a good effect and is free from toxic and side effects.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating rhinitis. Background technique [0002] Rhinitis refers to inflammation of the nasal mucosa and submucosal tissues. Manifested as congestion or edema, patients often have symptoms such as nasal congestion, runny nose, nasal itching, throat discomfort, and coughing. It is a clinically common disease, frequently-occurring disease, and stubborn and difficult to cure. At present, the methods for treating rhinitis are treated by antibiotics, antihistamines and traditional Chinese medicines such as Biyankang and Huodan Pills. Serious cases need to be treated with laser and surgery, but the effect is not obvious, and it is not easy to treat and recover. Come a lot of pain. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a pharmaceutical composition for treating rhinitis, which requires good rhinitis treatment effect and no toxic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8888A61P11/02A61K31/045A61K31/125A61K31/135A61K31/618A61K35/32
Inventor 钱家美
Owner 钱家美
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com